文献速递眼底病与葡萄膜炎

房水多组学纵向分析:GALNS耗竭是PDR抗VEGF治疗促纤维化介质

Longitudinal Multi-Omics Profiling of Aqueous Humor Implicates GALNS Depletion as a Pro-Fibrotic Mediator of Anti-VEGF Therapy in PDR.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

该研究对25例PDR患者(单纯玻璃体出血13例、玻璃体出血伴牵拉性视网膜脱离12例)在玻璃体腔注射阿柏西普前后7天进行房水蛋白质组学和代谢组学分析,发现GALNS在PDR中较白内障对照升高,但在牵拉性视网膜脱离及治疗后进一步下降,且GALNS敲低可促纤维化。

要点

  • 抗VEGF治疗前后房水多组学发现GALNS为唯一在横断面和纵向验证中均显著的促纤维化候选分子。
  • GALNS在PDR中较白内障对照升高,但在VH+TRD及抗VEGF治疗后下降,呈双相模式。
  • 成纤维细胞中GALNS敲低上调α-SMA和I型胶原、加速迁移并增强收缩力。

核心结论

  • GALNS耗竭可能是PDR抗VEGF治疗后促纤维化的分子,有望用于围手术期风险分层。

研究设计与样本

  • 前瞻性纵向研究,对25例PDR患者(单纯VH 13例、VH+TRD 12例)在玻璃体腔注射阿柏西普前及后7天采集房水行DIA蛋白质组学和广泛靶向代谢组学。
  • 在独立队列(白内障对照10例、单纯VH 5例、VH+TRD 5例)中用PRM/SRM验证候选分子,并通过siRNA敲低成纤维细胞中GALNS进行功能评估。

主要发现

  • 交集分析鉴定38个分子(5种蛋白质和33种代谢物),其中35个为改善型、3个为加重型(CAST、GALNS和3-HPA)。
  • 独立验证中仅GALNS在横断面(P = 0.016)和纵向(P = 0.049)比较中均获稳健验证,CAST和3-HPA未达统计学显著性。
  • GALNS呈双相模式:PDR中较白内障对照升高,VH+TRD中降低,治疗后进一步下降。
  • 成纤维细胞中GALNS敲低上调α-SMA和I型胶原、加速迁移并增强收缩力。

临床怎么用

  • GALNS可能作为PDR抗VEGF治疗围手术期纤维化风险的候选生物标志物,但需更大队列验证。

局限性

  • CAST和3-HPA仅为探索性候选,需在更大队列中验证。
  • 功能证据来自成纤维细胞siRNA敲低实验,尚未在体内或临床干预中证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Preoperative anti-vascular endothelial growth factor (VEGF) therapy in proliferative diabetic retinopathy (PDR) may exacerbate fibrovascular contraction, posing significant challenges. This study aims to characterize proteo-metabolomic changes induced by anti-VEGF therapy, validate key candidates on orthogonal analytical platforms, and provide functional evidence for the lead molecule. METHODS: Aqueous humor from 25 patients with PDR with simple vitreous hemorrhage (VH; n = 13) or VH with tractional retinal detachment (VH + TRD; n = 12) underwent data-independent acquisition (DIA) proteomics and widely targeted metabolomics before and 7 days after intravitreal aflibercept. Molecules altered in both cross-sectional and longitudinal comparisons were classified as "aggravation-type" or "improvement-type." Aggravation-type molecules were validated by parallel reaction monitoring/selected reaction monitoring (PRM/SRM) in an independent cohort (cataract controls, n = 10; simple VH, n = 5; VH + TRD, n = 5), and GALNS was functionally assessed by siRNA knockdown in fibroblasts. RESULTS: Intersection analysis identified 38 molecules (5 proteins and 33 metabolites): 35 improvement-type and 3 aggravation-type (CAST, GALNS, and 3-hydroxypropanoic acid [3-HPA]). Independent validation using PRM proteomics and SRM metabolomics confirmed that only GALNS was robustly validated across both cross-sectional (P = 0.016) and longitudinal (P = 0.049) comparisons, whereas CAST and 3-HPA did not reach statistical significance in validation. GALNS exhibited a biphasic pattern-elevated in PDR relative to cataract controls yet depleted in VH + TRD and further declined post-treatment. GALNS knockdown in fibroblasts upregulated α-SMA and collagen I, accelerated migration, and enhanced contractility. CONCLUSIONS: This multi-omics study, reinforced by independent validation, reveals GALNS depletion as a potential pro-fibrotic molecule following anti-VEGF therapy in PDR, offering a promising candidate for perioperative risk stratification. CAST and 3-HPA remain exploratory candidates requiring validation in larger cohorts.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Huang Y, Gui M, Kong X, et al. Longitudinal Multi-Omics Profiling of Aqueous Humor Implicates GALNS Depletion as a Pro-Fibrotic Mediator of Anti-VEGF Therapy in PDR. Invest Ophthalmol Vis Sci. 2026. PMID: 42149029. doi:10.1167/iovs.67.5.43

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。